Kinase inhibitors
US8907094B2 · kind B2 · utility
9Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2012 |
| Grant date | Dec 9, 2014 |
| Priority date | — |
| Expiry date | Dec 7, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and pharmaceutically acceptable salts thereof:wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.